Wu Jun
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unre Gastric Cancer, GastroEsophageal Cancer, Adenocarcinoma | Phase 2 | 2024-02-03 |
| Unknown | Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Gastric Cancer | Phase 2 | 2023-04-01 |